文献速递复苏、休克与脓毒症心脑血管急症重症综合管理与镇静镇痛

改善 presumed cardiac cause 难治性心脏骤停体外生命支持的插管时间——无现场心血管外科的导管室内两种经皮插管技术的比较

Improving cannulation time for extracorporeal life support in refractory cardiac arrest of presumed cardiac cause - Comparison of two percutaneous cannulation techniques in the catheterization laboratory in a center without on-site cardiovascular surgery.
PubMed 文献 · Resuscitation · 2017-11-26
一句话结论在无现场心血管外科的导管室,对 presumed cardiac cause 的难治性心脏骤停患者,超声引导加硬导丝经皮 vaECMO 插管时间较解剖标志加普通导丝缩短(中位 8 vs 17 分钟,p<0.001)。

单中心回顾性研究纳入2010至2016年46例年龄>18岁、因院外或院内难治性 presumed cardiac cause 心脏骤停接受 vaECMO 的患者,由介入心脏病学医师在导管室插管。比较第一时段(解剖标志穿刺加普通导丝)与第二时段(超声引导穿刺加硬导丝)的插管时间。总体插管成功42例(91%),插管时间中位14(10-21)分钟;第一时段17(12-26)分钟 vs 第二时段8(6-12)分钟,p<0.001。出院生存率9%,所有生存者初始心律均为可电击心律。

要点

  • 在无现场心血管外科的导管室,超声引导加硬导丝经皮 vaECMO 插管时间中位8(6-12)分钟,短于解剖标志加普通导丝的17(12-26)分钟(p<0.001)。
  • 46例 presumed cardiac cause 难治性心脏骤停患者中,插管成功42例(91%),总体插管时间中位14(10-21)分钟。
  • 院外 vs 院内难治性心脏骤停:从心脏骤停到 vaECMO 时间120(115-140) vs 82(58-102)分钟(p=0.011),出院生存7%(2例) vs 11%(2例)(p=0.35)。
  • 出院生存率9%,所有生存者初始心律均为可电击心律。
  • 人群特征:年龄56(49-62)岁,可电击初始心律29例(63%),缺血性心脏病36例(78%),急性心肌梗死26例(57%),院外难治性心脏骤停27例(59%)。

适用人群与场景

  • 年龄>18岁、因院外或院内难治性 presumed cardiac cause 心脏骤停接受 vaECMO 的患者,由介入心脏病学医师在导管室插管。
  • 研究在无现场心血管外科的大学医院进行,2010至2016年间纳入。

处置流程与药物剂量

  • 第一时段采用解剖标志血管穿刺加普通导丝进行经皮 vaECMO 插管。
  • 第二时段采用超声引导穿刺加硬导丝进行经皮 vaECMO 插管。

研究设计与关键结果

  • 单中心回顾性研究,纳入46例患者,年龄56(49-62)岁,第一时段34例;可电击初始心律29例(63%),缺血性心脏病36例(78%),急性心肌梗死26例(57%),院外难治性心脏骤停27例(59%)。
  • 从院外难治性心脏骤停到入院时间100(80-118)分钟。
  • 插管成功42例(91%);总体插管时间中位14(10-21)分钟,第一时段17(12-26)分钟 vs 第二时段8(6-12)分钟,p<0.001。
  • 出院生存率9%;院外 vs 院内从心脏骤停到 vaECMO 时间120(115-140) vs 82(58-102)分钟,p=0.011;出院生存院外7%(2例) vs 院内11%(2例),p=0.35。
  • 所有生存者初始心律均为可电击心律。

证据类型、等级与局限

  • 证据类型:单中心回顾性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在无现场心血管外科的导管室,对 presumed cardiac cause 的难治性心脏骤停患者行经皮 vaECMO 插管时,作者结论认为使用超声引导和硬导丝可缩短插管时间。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Cardiac arrest (CA) without return of spontaneous circulation can be treated with veno-arterial extracorporeal membrane oxygenation (vaECMO) implemented surgically or percutaneously. We performed a study assessing time for vaECMO percutaneous cannulation in the catheterization laboratory.

METHODS: Single-centre retrospective study in a University hospital without on-site cardiovascular surgery, including patients aged >18 receiving vaECMO for out- or in-hospital refractory CA of presumed cardiac cause between 2010 and 2016, cannulated by interventional cardiologists. Cannulation time using anatomic landmarks vessel puncture and conventional wires (first period) was compared with ultrasound guidance puncture and stiff wires (second period). Data are expressed as medians (interquartile range) and percentages.

RESULTS: Forty-six patients were included, age 56 (49-62), 34 in the first period. Shockable initial rhythm occurred in 29 (63%), 36 (78%) had ischemic heart disease and 26 (57%) acute myocardial infarction (AMI). Out-of-hospital refractory CA occurred in 27 (59%) patients. Time from out-of-hospital refractory CA to admission was 100 (80-118) min. Cannulation was successful in 42 (91%) patients. Cannulation time was 14 (10-21) min, 17 (12-26) (first) and 8 (6-12) min (second period), p<0.001. Survival to discharge was 9%. In out-of-hospital versus in-hospital, time from CA to vaECMO was 120 (115-140) versus 82 (58-102) min, p=0.011, survival was 7% (two patients) versus 11% (two patients), p=0.35 respectively. All survivors had shockable initial rhythm.

CONCLUSION: In these refractory CA patients with high prevalence of AMI and good feasibility of percutaneous vaECMO in the catheterization laboratory, cannulation time was shorter using ultrasound guidance and stiff wires.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Voicu S, Henry P, Malissin I, et al. Improving cannulation time for extracorporeal life support in refractory cardiac arrest of presumed cardiac cause - Comparison of two percutaneous cannulation techniques in the catheterization laboratory in a center without on-site cardiovascular surgery. Resuscitation. 2017. PMID: 29183830. doi:10.1016/j.resuscitation.2017.11.057

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。